People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Neuroscience Corp | — | Other Health Care | Series C | $172.3M | $713.2M | 2022 |
Eric M. Attias at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric M. Attias on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Chen | 1 | 7 |
| Michael Mager | 1 | 4 |
| Howard M. Morgan | 1 | 1 |
| MIchael M. Kaswan | 1 | 1 |
| Benjamin Rapoport | 1 | 1 |
| Ravi Mehta | 1 | 1 |
| Mike M. Kaswan | 1 | 1 |
| Craig Mermel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.